Drug profile · INN
estetrol + drospirenone
NEXTSTELLIS
estetrol + drospirenone (NEXTSTELLIS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — estetrol + drospirenone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
estetrol + drospirenone (NEXTSTELLIS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is estetrol + drospirenone?
estetrol + drospirenone (NEXTSTELLIS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for estetrol + drospirenone?
NEXTSTELLIS is a marketed brand name for estetrol + drospirenone. Check FDA Drugs@FDA for the current US label holder and prescribing information.